S&P 500 may face selling pressure as systematic funds reach full exposure
PROVO, Utah - Nu Skin Enterprises Inc. (NYSE:NUS) saw its shares surge 16.2% after the company reported fourth-quarter earnings and revenue that exceeded analyst expectations, while also providing strong guidance for the upcoming year.
The beauty and wellness products maker posted adjusted earnings per share of $0.38, surpassing the analyst estimate of $0.22. Revenue for the quarter came in at $445.6 million, beating the consensus estimate of $433.83 million. However, this represents an 8.8% YoY decline, with a 4.1% negative impact from foreign exchange rates.
Nu Skin’s Rhyz segment showed strong growth, with revenue increasing 27.7% to $83.1 million in the fourth quarter.
"We were pleased to beat our fourth quarter revenue guidance, generate sequential revenue growth and exceed our adjusted earnings as we materially completed our restructuring plan," said Ryan Napierski, Nu Skin president and CEO.
For the first quarter of 2025, Nu Skin expects revenue between $345 million and $365 million, below the analyst consensus of $404 million. The company projects full-year 2025 revenue of $1.48 billion to $1.62 billion, with adjusted EPS ranging from $0.90 to $1.30, excluding gains from the sale of Mavely.
Nu Skin anticipates improving business trends and a return to YoY growth in several markets in 2025, despite ongoing economic challenges and poor consumer sentiment in Greater China and South Korea.
The company plans to focus on strengthening its core business and accelerating growth in developing markets, particularly Latin America. Nu Skin also expects to introduce Prysm iO™, an intelligent wellness device, later this year to drive growth in its nutrition segment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.